ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma

Genomic correlates of response to immune checkpoint blockade

(2019) Tanya E. Keenan et al.   NATURE MEDICINE

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

(2019) Junfei Zhao et al.   NATURE MEDICINE

Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors

(2018) Philippe Marchetti et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

The Immune Landscape of Cancer

(2018) Vésteinn Thorsson et al.   IMMUNITY

Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies

(2018) Mony Chenda Morisse et al.   Expert Review of Neurotherapeutics

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

(2018) Livnat Jerby-Arnon et al.   CELL

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

(2018) Miguel F. Sanmamed et al.   CELL

Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages

(2018) Toszka Bohn et al.   NATURE IMMUNOLOGY

Tumors sweeten macrophages with acids

(2018) Hiroki Sekine et al.   NATURE IMMUNOLOGY

The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors

(2017) Mark C. de Gooijer et al.   INTERNATIONAL JOURNAL OF CANCER

A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma

(2017) Ricarda Hannen et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Recurrent glioma clinical trial, CheckMate-143: the game is not over yet

(2017) Anna C. Filley et al.   Oncotarget

Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents

(2017) Oakley C. Olson et al.   Cell Reports

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma

(2016) Wei Wei et al.   CANCER CELL

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

(2016) Peter J.R. Ebert et al.   IMMUNITY

Epidemiologic and Molecular Prognostic Review of Glioblastoma

(2014) J. P. Thakkar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Somatic Genomic Landscape of Glioblastoma

(2013) Cameron W. Brennan et al.   CELL

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

(2013) Stephanie M Pyonteck et al.   NATURE MEDICINE

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

(2012) Zakaria Ezzoukhry et al.   INTERNATIONAL JOURNAL OF CANCER

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery